Comments: NJ A1526 | 2024-2025 | Regular Session

Bill Title: Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced) 2024-01-09 - Introduced, Referred to Assembly Judiciary Committee [A1526 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2024 New Jersey A1526 at this time.

Social Comments on NJ A1526

feedback